450 related articles for article (PubMed ID: 17226843)
1. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
Burke MJ; Cohn SL
Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
[TBL] [Abstract][Full Text] [Related]
3. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.
Rostásy K; Wilken B; Baumann M; Müller-Deile K; Bieber I; Gärtner J; Möller P; Angelini P; Hero B
Neuropediatrics; 2006 Oct; 37(5):291-5. PubMed ID: 17236108
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
Chang BH; Koch T; Hopkins K; Malempati S
Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
[TBL] [Abstract][Full Text] [Related]
5. Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses.
Wilken B; Baumann M; Bien CG; Hero B; Rostasy K; Hanefeld F
Eur J Paediatr Neurol; 2008 Jan; 12(1):51-5. PubMed ID: 17625938
[TBL] [Abstract][Full Text] [Related]
6. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
[TBL] [Abstract][Full Text] [Related]
7. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
8. Another promising treatment option for neuroblastoma-associated opsoclonus-myoclonus syndrome by oral high-dose dexamethasone pulse: lymphocyte markers as disease activity.
Oguma M; Morimoto A; Takada A; Kashii Y; Fukuda T; Mori M; Yamagata T; Sugie H; Momoi MY
Brain Dev; 2012 Mar; 34(3):251-4. PubMed ID: 21531096
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
[TBL] [Abstract][Full Text] [Related]
10. The opsoclonus–myoclonus syndrome.
Sahu JK; Prasad K
Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
[TBL] [Abstract][Full Text] [Related]
11. [Opsoclonus myoclonus ataxia syndrome in Israel].
Blumkin L; Lerman-Sagie T
Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
[TBL] [Abstract][Full Text] [Related]
12. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
13. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
14. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
Bell J; Moran C; Blatt J
Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
[TBL] [Abstract][Full Text] [Related]
15. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
[TBL] [Abstract][Full Text] [Related]
16. The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review.
Mizia-Malarz A; Stolpa W; Sobol-Milejska G
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823831
[No Abstract] [Full Text] [Related]
17. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic presentation in the emergency department: a case report of a girl with "shimmering eyes".
Krivochenitser R; Lemma Y; Wynn B; Jones JS
J Emerg Med; 2014 Jun; 46(6):e163-5. PubMed ID: 24698510
[TBL] [Abstract][Full Text] [Related]
19. Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments.
Battaglia T; De Grandis E; Mirabelli-Badenier M; Boeri L; Morcaldi G; Barabino P; Intra C; Naselli F; Pistoia V; Veneselli E; Conte M
Eur J Paediatr Neurol; 2012 Mar; 16(2):192-5. PubMed ID: 21737325
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
